Critical appraisals of the papers behind ED practice, plus challenging common dogma. Search, browse by section or A–Z, or see what’s newest.
Name | Question | Bottom line | Kind | Verdict | Section | Study type | Last updated | Featured | We were taught | Evidence says |
|---|---|---|---|---|---|---|---|---|---|---|
Is a MAP of 60–65 good enough for patients 65 and older? | No significant difference in 90-day mortality; a possible benefit with chronic hypertension. | Dogma | Still debated | Resuscitation & Critical Care | Trial | April 3, 2025 | Keep the MAP at 65 or higher in shock. | In patients 65+, a MAP of 60–65 didn’t significantly change 90-day mortality. | ||
Can an age-adjusted D-dimer rule out PE at high pretest probability? | No missed PE in a 651-patient post hoc analysis, but the confidence interval is too wide to change practice yet. | Lit review | Pulmonary | Trial | March 18, 2025 | |||||
Does a second defibrillator, or a new pad position, help refractory VF? | In DOSE-VF, survival to discharge was more frequent with double sequential shocks or a change in pad position. | Emerging evidence | Resuscitation & Critical Care | Trial | February 22, 2025 | Refractory VF: keep shocking the same way. | DOSE-VF: more survival to discharge with double sequential shocks or a new pad position. | |||
Should methylene blue come earlier than “last resort” in septic shock? | Given early, it shortened vasopressor time and length of stay in one trial. | Emerging evidence | Resuscitation & Critical Care | Trial | April 3, 2025 | |||||
Which older adults who fall from standing are at risk of traumatic ICH? | Focal deficits, visible head trauma, LOC and male sex predict ICH (6.8% overall). Not ready to skip CT: no validated rule yet. | Lit review | Trauma & Ortho | Trial | August 6, 2025 | |||||
What does heparin actually add in ACS? | No mortality benefit and only a temporary drop in MI, with major bleeding in about 1 in 25. Its role in NSTEMI without early PCI is unclear. | Dogma | Challenges dogma | Cardiovascular | Topic review | February 17, 2025 | Every ACS patient needs heparin. | No mortality benefit; the drop in MI fades by 30 days, and about 1 in 25 have a major bleed. | ||
Is the classic slow-correction rule for hypernatremia too cautious? | Faster correction (up to ~1 mmol/L/hr) may lower mortality in severe or admission hypernatremia, especially in the first 24 h. Observational data only: monitor closely. | Dogma | Still debated | Renal/GU & Endocrine | Trial | June 3, 2025 | Never correct sodium faster than 0.5 mmol/L/hr. | Faster correction was linked to lower mortality in severe or admission hypernatremia; no RCTs, neuro data thin. | ||
Does IV contrast really cause acute kidney injury? | Don't withhold or delay indicated contrast CT. Routine prehydration adds no benefit. | Dogma | Challenges dogma | Renal/GU & Endocrine | Topic review | February 17, 2025 | IV contrast causes AKI, so wait for a creatinine first. | Large cohorts and a meta-analysis: no more AKI, dialysis or death after contrast CT. | ||
Does naloxone change outcomes in out-of-hospital cardiac arrest? | Outcomes were similar to usual care, even though naloxone patients were younger and healthier. | Emerging evidence | Toxicology | Trial | January 27, 2025 | |||||
Are nitrates truly contraindicated in right ventricular MI? | The absolute contraindication isn’t supported: serious adverse events weren’t significantly increased. Stay cautious with hypotension. | Dogma | Challenges dogma | Cardiovascular | Topic review | November 20, 2026 | Never give nitrates in a right ventricular MI. | The absolute contraindication isn’t supported. Stay cautious with hypotension. | ||
How long must a naloxone-revived patient be watched? | After heroin overdose, patients with normal mentation and vital signs had very low risk when released without transport. | Dogma | Challenges dogma | Toxicology | Trial | January 26, 2025 | Everyone revived with naloxone needs hours of observation. | After heroin overdose, normal mentation and vital signs meant very low risk without transport. | ||
What happens to patients after an ED visit for opioid overdose? | A nonfatal overdose predicts death within a year. Starting MOUD in the ED saves lives and keeps patients in treatment. | Dogma | Challenges dogma | Toxicology | Topic review | February 8, 2025 | Reverse the overdose, observe, discharge. MOUD can wait. | 1-year mortality after a nonfatal overdose is 4–15%; MOUD roughly halves it. | ||
Do known psychiatric patients need routine labs before admission? | Routine labs are generally not recommended; let history and exam guide testing. | Dogma | Challenges dogma | Special Populations | Topic review | January 1, 2025 | Every psychiatric patient needs routine labs. | Generally not recommended for known psychiatric patients; let history and exam guide testing. | ||
What do the current sepsis guidelines ask of the ED? | No high-quality evidence shows SEP-1 compliance improves sepsis outcomes. Treat by severity and clinical judgment, not the checklist. | Dogma | Still debated | Resuscitation & Critical Care | Guideline | March 20, 2025 | Hit every SEP-1 bundle element on time and sepsis mortality drops. | 17 observational studies, none low-bias: no consistent proof SEP-1 compliance lowers mortality. | ||
Is adenosine really the better first drug for stable SVT? | Conversion rates are similar (about 90% vs 93%); adenosine works faster. | Dogma | Challenges dogma | Cardiovascular | Topic review | June 30, 2025 | Adenosine is the first drug for stable SVT. | Similar conversion rates (about 90% vs 93%); adenosine is faster, CCBs are a fair first choice. | ||
Does hospital-level cath lab performance change STEMI mortality? | Missing the 90/120-min PCI target doubled the odds of in-hospital death (NNT 19–32). About half of patients missed it, especially transfers. | Lit review | Cardiovascular | Trial | June 11, 2025 | |||||
Cool to 33 °C after cardiac arrest, or just prevent fever? | Prevent fever (keep it under 37.5–37.7 °C) for at least 72 hours. Routine hypothermia adds no proven benefit. | Dogma | Challenges dogma | Resuscitation & Critical Care | Topic review | December 4, 2024 | Cool every comatose post-arrest patient to 32–34 °C. | TTM2: 33 °C was no better than normothermia with fever prevention for survival or neuro outcome. |

